Literature DB >> 22045864

Complementary and alternative medicine practitioners' standard of care: responsibilities to patients and parents.

Joan Gilmour1, Christine Harrison, Leyla Asadi, Michael H Cohen, Sunita Vohra.   

Abstract

In this article we explain (1) the standard of care that health care providers must meet and (2) how these principles apply to complementary and alternative medicine practitioners. The scenario describes a 14-year-old boy who is experiencing back pain and whose chiropractor performed spinal manipulation but did not recognize or take steps to rule out serious underlying disease-in this case, testicular cancer--either initially or when the patient's condition continued to deteriorate despite treatment. We use chiropractic care for a patient with a sore back as an example, because back pain is such a common problem and chiropracty is a common treatment chosen by both adult and pediatric patients. The scenario illustrates the responsibilities that complementary and alternative medicine practitioners owe patients/parents, the potential for liability when deficient care harms patients, and the importance of ample formal pediatric training for practitioners who treat pediatric patients.

Entities:  

Mesh:

Year:  2011        PMID: 22045864     DOI: 10.1542/peds.2010-2720J

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

Review 1.  Ethical and Legal Considerations of Alternative Neurotherapies.

Authors:  Ashwini Nagappan; Louiza Kalokairinou; Anna Wexler
Journal:  AJOB Neurosci       Date:  2021-03-24

Review 2.  Applying an Ethical Framework to Herbal Medicine.

Authors:  Kate Chatfield; Bahare Salehi; Javad Sharifi-Rad; Leila Afshar
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-19       Impact factor: 2.629

Review 3.  Natural Products in Neurodegenerative Diseases: A Great Promise but an Ethical Challenge.

Authors:  Marco Di Paolo; Luigi Papi; Federica Gori; Emanuela Turillazzi
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.